Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Colorcon
Cantor Fitzgerald
Julphar
Farmers Insurance
Medtronic
Citi
Merck
Mallinckrodt
Novartis

Generated: August 19, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: levomilnacipran hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Forest Labs Inc
FETZIMA
levomilnacipran hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2202-281 KIT in 1 BLISTER PACK (0456-2202-28)
Forest Labs Inc
FETZIMA
levomilnacipran hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2212-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2212-30)
Forest Labs Inc
FETZIMA
levomilnacipran hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2212-9090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2212-90)
Forest Labs Inc
FETZIMA
levomilnacipran hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2220-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2220-30)
Forest Labs Inc
FETZIMA
levomilnacipran hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2240-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2240-30)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Julphar
Harvard Business School
Covington
Farmers Insurance
Teva
Dow
Chubb
Merck
Johnson and Johnson

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot